30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

PhaseBio Pharmaceuticals Inc (PHAS)

Track

Stock chart
Ticker: PHAS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
NEW ENTERPRISE ASSOCIATES 13 LP
1 sale — total 262,264 USD
Sale 25 Oct 2022
Value US$4,978,942.44 | Price 277.64 | Shares 75,544
Planned sale 23 May 2022
Value US$2,876,297.33 | Price 462.01 | Shares 60,749
Planned sale 19 Nov 2021
Value US$13,665.42 | Price 2.37 | Shares 5,766
Sale 20 May 2021
Value US$12,538.19 | Price 3.29 | Shares 3,811
Buy 3 Dec 2020
Value US$24,720.00 | Price 4.12 | Shares 6,000
Buy 24 Nov 2020
Value US$7,000.00 | Price 3.50 | Shares 2,000
Buy 23 Nov 2020
Value US$11,010.00 | Price 3.67 | Shares 3,000
Sale 23 Nov 2020
Value US$12,064.65 | Price 3.45 | Shares 3,497
Planned sale 1 Jul 2019
Value US$6,426.00 | Price 14.00 | Shares 459
Planned sale 1 Jul 2019
Value US$3,570.00 | Price 14.00 | Shares 255
Planned sale 1 Jul 2019
Value US$2,520.00 | Price 14.00 | Shares 180
Planned sale 1 Jul 2019
Value US$28,196.00 | Price 14.00 | Shares 2,014
Planned sale 18 Jun 2019
Value US$882.00 | Price 14.00 | Shares 63
Planned sale 18 Jun 2019
Value US$490.00 | Price 14.00 | Shares 35
Planned sale 18 Jun 2019
Value US$350.00 | Price 14.00 | Shares 25
Planned sale 18 Jun 2019
Value US$3,878.00 | Price 14.00 | Shares 277
Buy 17 Dec 2018
Value US$4,460.00 | Price 4.46 | Shares 1,000
Buy 13 Dec 2018
Value US$3,940.00 | Price 3.94 | Shares 1,000
Buy 13 Dec 2018
Value US$3,690.00 | Price 3.69 | Shares 1,000
Buy 11 Dec 2018
Value US$5,820.00 | Price 3.88 | Shares 1,500
Buy 10 Dec 2018
Value US$3,080.00 | Price 3.85 | Shares 800
Buy 7 Dec 2018
Value US$19,200.00 | Price 3.84 | Shares 5,000
Buy 7 Dec 2018
Value US$8,536.00 | Price 3.88 | Shares 2,200
Buy 4 Dec 2018
Value US$12,520.00 | Price 3.13 | Shares 4,000
Buy 22 Oct 2018
Value US$750,000.00 | Price 5.00 | Shares 150,000
Buy 22 Oct 2018
Value US$62,435.00 | Price 5.00 | Shares 12,487
Buy 22 Oct 2018
Value US$687,565.00 | Price 5.00 | Shares 137,513
Buy 22 Oct 2018
Value US$3,000,000.00 | Price 5.00 | Shares 600,000
Buy 22 Oct 2018
Value US$9,000,000.00 | Price 5.00 | Shares 1,800,000
Buy 22 Oct 2018
Value US$30,205.00 | Price 5.00 | Shares 6,041
Buy 22 Oct 2018
Value US$6,385.00 | Price 5.00 | Shares 1,277
Buy 22 Oct 2018
Value US$63,410.00 | Price 5.00 | Shares 12,682
Buy 22 Oct 2018
Value US$750,000.00 | Price 5.00 | Shares 150,000
Buy 22 Oct 2018
Value US$62,435.00 | Price 5.00 | Shares 12,487
Buy 22 Oct 2018
Value US$687,565.00 | Price 5.00 | Shares 137,513
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-10-26 2022-10-25 S Sale
2.5
NEW ENTERPRISE ASSOCIATES 13 LP
Large shareholder
75,544 +47.0%
277.64
US$4,978,942 		75,544 +47.0% 277.64 US$4,978,942
2022-05-24 2022-05-23 PlS Planned sale
1.8
Burkhardt Glen

SVP of Human Resources

Officer
60,749 -19.8%
462.01
US$2,876,297 		60,749 -19.8% 462.01 US$2,876,297
2021-11-23 2021-11-19 PlS Planned sale
1.8
Burkhardt Glen

VP, Human Resources

Officer
92,380 +20.7%
207.32
US$4,234,913 		92,380 +20.7% 207.32 US$4,234,913
2021-05-24 2021-05-20 S Sale
1.8
Burkhardt Glen

VP, Human Resources

Officer
3,811 -100.0%
3.29
US$12,538 		3,811 -100.0% 3.29 US$12,538
2020-12-04 2020-12-03 B Purchase
0.8
HARRIGAN EDMUND
Non-Executive Director
6,000 +inf%
4.12
US$24,720 		6,000 +inf% 4.12 US$24,720
2020-11-24 2020-11-24 B Purchase
3.7
Thorp Clay
Non-Executive Director
2,000 +9.5%
3.50
US$7,000 		2,000 +9.5% 3.50 US$7,000
2020-11-24 2020-11-23 B Purchase
3.7
Thorp Clay
Non-Executive Director
3,000 +16.7%
3.67
US$11,010 		3,000 +16.7% 3.67 US$11,010
2020-11-23 2020-11-23 S Sale
1.8
Burkhardt Glen

VP, Human Resources

Officer
3,497 -100.0%
3.45
US$12,065 		3,497 -100.0% 3.45 US$12,065
2019-07-03 2019-07-01 PlS Planned sale
3.7
Thorp Clay
Large shareholder
459 -0.1%
14.00
US$6,426 		459 -0.1% 14.00 US$6,426
2019-07-03 2019-07-01 PlS Planned sale
3.7
Thorp Clay
Large shareholder
255 -0.5%
14.00
US$3,570 		255 -0.5% 14.00 US$3,570
2019-07-03 2019-07-01 PlS Planned sale
3.7
Thorp Clay
Large shareholder
180 -0.1%
14.00
US$2,520 		180 -0.1% 14.00 US$2,520
2019-07-03 2019-07-01 PlS Planned sale
3.7
Thorp Clay
Large shareholder
2,014 -0.1%
14.00
US$28,196 		2,014 -0.1% 14.00 US$28,196
2019-06-20 2019-06-18 PlS Planned sale
3.7
Thorp Clay
Large shareholder
63 -0.0%
14.00
US$882 		63 -0.0% 14.00 US$882
2019-06-20 2019-06-18 PlS Planned sale
3.7
Thorp Clay
Large shareholder
35 -0.1%
14.00
US$490 		35 -0.1% 14.00 US$490
2019-06-20 2019-06-18 PlS Planned sale
3.7
Thorp Clay
Large shareholder
25 -0.0%
14.00
US$350 		25 -0.0% 14.00 US$350
2019-06-20 2019-06-18 PlS Planned sale
3.7
Thorp Clay
Large shareholder
277 -0.0%
14.00
US$3,878 		277 -0.0% 14.00 US$3,878
2018-12-17 2018-12-17 B Purchase
3.7
Hutson Nancy J
Non-Executive Director
1,000 +inf%
4.46
US$4,460 		1,000 +inf% 4.46 US$4,460
2018-12-17 2018-12-13 B Purchase Ballance David James

VP, Research and Sci. Affairs

Officer
1,000 +15.2%
3.94
US$3,940 		1,000 +15.2% 3.94 US$3,940
2018-12-17 2018-12-13 B Purchase
1.9
Mow Jonathan P

Chief Executive Officer

Executive Director
1,000 +2.0%
3.69
US$3,690 		1,000 +2.0% 3.69 US$3,690
2018-12-11 2018-12-11 B Purchase York Michael

VP, Corporate Development

Officer
1,500 +inf%
3.88
US$5,820 		1,500 +inf% 3.88 US$5,820
2018-12-11 2018-12-10 B Purchase
1.9
Mow Jonathan P

Chief Executive Officer

Executive Director
800 +1.6%
3.85
US$3,080 		800 +1.6% 3.85 US$3,080
2018-12-11 2018-12-07 B Purchase
1.6
Sharp John P

CFO and Secretary

Officer
5,000 +inf%
3.84
US$19,200 		5,000 +inf% 3.84 US$19,200
2018-12-11 2018-12-07 B Purchase
1.9
Mow Jonathan P

Chief Executive Officer

Executive Director
2,200 +4.5%
3.88
US$8,536 		2,200 +4.5% 3.88 US$8,536
2018-12-06 2018-12-04 B Purchase
3.7
Thorp Clay
Non-Executive Director Large shareholder
4,000 +33.9%
3.13
US$12,520 		4,000 +33.9% 3.13 US$12,520
2018-10-24 2018-10-22 B Purchase
3.7
Thorp Clay
Non-Executive Director Large shareholder
150,000 +56.3%
5.00
US$750,000 		150,000 +56.3% 5.00 US$750,000
2018-10-24 2018-10-22 B Purchase
3.7
Thorp Clay
Non-Executive Director Large shareholder
12,487 +8.3%
5.00
US$62,435 		12,487 +8.3% 5.00 US$62,435
2018-10-24 2018-10-22 B Purchase
3.7
Thorp Clay
Non-Executive Director Large shareholder
137,513 +8.2%
5.00
US$687,565 		137,513 +8.2% 5.00 US$687,565
2018-10-24 2018-10-22 B Purchase ASTRAZENECA PLC Large shareholder
600,000 +25.0%
5.00
US$3,000,000 		600,000 +25.0% 5.00 US$3,000,000
2018-10-24 2018-10-22 B Purchase NEW ENTERPRISE ASSOCIATES 13 LP Large shareholder
1,800,000 +37.2%
5.00
US$9,000,000 		1,800,000 +37.2% 5.00 US$9,000,000
2018-10-24 2018-10-22 B Purchase TUFTS LINDA Non-Executive Director
6,041 +2.2%
5.00
US$30,205 		6,041 +2.2% 5.00 US$30,205
2018-10-24 2018-10-22 B Purchase TUFTS LINDA Non-Executive Director
1,277 +2.2%
5.00
US$6,385 		1,277 +2.2% 5.00 US$6,385
2018-10-24 2018-10-22 B Purchase TUFTS LINDA Non-Executive Director
12,682 +2.2%
5.00
US$63,410 		12,682 +2.2% 5.00 US$63,410
2018-10-24 2018-10-22 B Purchase Hatteras Venture Advisors III, LLC Large shareholder
150,000 +56.3%
5.00
US$750,000 		150,000 +56.3% 5.00 US$750,000
2018-10-24 2018-10-22 B Purchase Hatteras Venture Advisors III, LLC Large shareholder
12,487 +8.3%
5.00
US$62,435 		12,487 +8.3% 5.00 US$62,435
2018-10-24 2018-10-22 B Purchase Hatteras Venture Advisors III, LLC Large shareholder
137,513 +8.2%
5.00
US$687,565 		137,513 +8.2% 5.00 US$687,565
Explore more

More insider trading research around PhaseBio Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America